XGEN Venture: Investment Portfolio & Startup News

XGEN Venture

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

$EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy$ $EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy$

EpilepsyGTx

10 Dec 2025

EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy

EpilepsyGTx develops gene therapies for severe epilepsy, aiming to stop seizures with a single targeted treatment rather than long-term medication.

XGEN Venture

- Life Sciences
1(12 months)
xgenventure.com
Update Information

More venture news

DYAD
29 Sept 2026
DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
Series AHealth
Sprive
21 Sept 2026
Sprive unlocks an £8m Series A from VCs to help homeowners pay down their mortgages
Series AFintech
Magentic
17 Sept 2026
Magentic closes £13m Series A led by Felicis to put AI workers inside the procurement teams of global manufacturers
Series ASupply Chain

XGEN Venture: Investment Portfolio & Startup News

Investment Portfolio

EpilepsyGTx secures £25m Series A from investors to advance gene therapies for refractory epilepsy

More venture news

DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records

Sprive unlocks an £8m Series A from VCs to help homeowners pay down their mortgages

Magentic closes £13m Series A led by Felicis to put AI workers inside the procurement teams of global manufacturers